Slideshow
Author(s):
A study undertaken to evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine has led to an FDA extended indication.
FDA Action Update, September 2024: Approvals, Designations, and Clearances
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
Discontinuation Patterns Provide Support for Long-Term Effectiveness of Erenumab
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
College Checklist for People Living With Migraine
Letter From the Editor – Fall 2024